Protagonist Therapeutics Inc (NASDAQ:PTGX)

Delayed Data
As of 4:00pm ET
 +0.97 / +3.13%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Protagonist Therapeutics Inc have a median target of 55.00, with a high estimate of 93.00 and a low estimate of 40.00. The median estimate represents a +72.25% increase from the last price of 31.93.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Protagonist Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 2.90%
Growthannually -31.92%


Growthquarterly -23.05%
Growthannually -50.49%
Key to the earnings and sales forecast charts.